Haifa, Israel

Ofra Kessler

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2012-2020

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Ofra Kessler: Innovator in Eye Disease Treatment

Introduction

Ofra Kessler is a prominent inventor based in Haifa, Israel, known for her significant contributions to the field of medical sciences. With a total of six patents to her name, Kessler has focused her research on innovative treatments for eye diseases and cancer.

Latest Patents

Kessler's latest patents include groundbreaking work on Semaphorin 3C variants and their applications in treating eye diseases. One of her notable inventions involves methods for treating age-related macular degeneration (AMD) by administering Semaphorin 3C or its variants, which have been modified to resist cleavage at specific sites. Additionally, her research explores the use of these variants in compositions aimed at suppressing tumor growth and inhibiting metastasis.

Career Highlights

Throughout her career, Kessler has been associated with the Rappaport Family Institute for Research in the Medical Sciences, where she has conducted extensive research. Her work has not only advanced the understanding of eye diseases but has also contributed to the development of potential cancer therapies.

Collaborations

Kessler has collaborated with notable colleagues, including Gera Neufeld and Boaz Kigel, enhancing the impact of her research through teamwork and shared expertise.

Conclusion

Ofra Kessler's innovative work in the field of medical sciences, particularly in the treatment of eye diseases and cancer, showcases her dedication to advancing healthcare solutions. Her contributions through patents and research collaborations continue to pave the way for future advancements in these critical areas.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…